George Kuo
38Patents
23h-index
28Co-inventors
85Inventor score
Filing activity: Jan 6, 1982 → Aug 13, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5350671A | HCV immunoassays employing C domain antigens | Emerging Cross-Sectional Technologies | 147 | Expired |
| US4722840A | Hybrid particle immunogens | Emerging Cross-Sectional Technologies | 118 | Expired |
| US5683864A | Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies | Emerging Cross-Sectional Technologies | 71 | Expired |
| US5714596A | NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus | Emerging Cross-Sectional Technologies | 70 | Expired |
| US5712088A | Methods for detecting Hepatitis C virus using polynucleotides specific for same | Chemistry; Metallurgy | 61 | Expired |
| US6027729A | NANBV Diagnostics and vaccines | Emerging Cross-Sectional Technologies | 58 | Expired |
| US5371017A | Hepatitis C virus protease | Chemistry; Metallurgy | 56 | Expired |
| US6171782A | Antibody compositions to HCV and uses thereof | Emerging Cross-Sectional Technologies | 50 | Expired |
| US5597691A | Hepatitis C virus protease | Chemistry; Metallurgy | 47 | Expired |
| US5585258A | Hepatitis C virus protease | Chemistry; Metallurgy | 46 | Expired |
| US5712145A | Hepatitis C virus protease | Chemistry; Metallurgy | 46 | Expired |
| US6074816A | NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus | Emerging Cross-Sectional Technologies | 45 | Expired |
| US5712087A | Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens | Emerging Cross-Sectional Technologies | 44 | Expired |
| US5863719A | Methods for detecting hepatitis C virus using polynucleotides specific for same | Chemistry; Metallurgy | 41 | Expired |
| US5942234A | Hepatitis C virus asialoglycoproteins | Emerging Cross-Sectional Technologies | 40 | Expired |
| US5698390A | Hepatitis C immunoassays | Emerging Cross-Sectional Technologies | 39 | Expired |
| US6096541A | Cell culture systems for HCV | Emerging Cross-Sectional Technologies | 38 | Expired |
| US6074846A | Hepatitis C virus asialoglycoproteins | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6312889A | Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies | Emerging Cross-Sectional Technologies | 32 | Expired |
| US5004804A | Method and composition for preparation of factor VIIIC | Human Necessities | 29 | Expired |
| US6274148A | Hepatitis C virus asialoglycoproteins | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6074852A | Hepatitis C virus asialoglycoproteins | Emerging Cross-Sectional Technologies | 25 | Expired |
| US7105303B2 | Antibodies to hepatitis C virus asialoglycoproteins | Emerging Cross-Sectional Technologies | 25 | Expired |
| US7138505B1 | Factor VIII:C nucleic acid molecules | Chemistry; Metallurgy | 23 | Expired |
| US5045455A | Factor VIII:C cDNA cloning and expression | Human Necessities | 22 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.